1-Pamitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol May Reduce Incidence of Gemcitabine-Induced Neutropenia: A Pilot Case-Controlled Study.

about

1-Pamitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol May Reduce Incidence of Gemcitabine-Induced Neutropenia: A Pilot Case-Controlled Study.

Item

http://www.wikidata.org/entity/Q41958401

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

1-Pamitoyl-2-Linoleoyl-3-Acety ...... A Pilot Case-Controlled Study.

@en

type

Item

label

1-Pamitoyl-2-Linoleoyl-3-Acety ...... A Pilot Case-Controlled Study.

@en

prefLabel

1-Pamitoyl-2-Linoleoyl-3-Acety ...... A Pilot Case-Controlled Study.

@en

P1476

1-Pamitoyl-2-Linoleoyl-3-Acety ...... A Pilot Case-Controlled Study

@en

P2093

Charles J Cho

http://www.w3.org/2001/XMLSchema#string

Jae Wha Kim

http://www.w3.org/2001/XMLSchema#string

Joo Hyun Chun

http://www.w3.org/2001/XMLSchema#string

Kwangwoo Nam

http://www.w3.org/2001/XMLSchema#string

Kyoungwon Jung

http://www.w3.org/2001/XMLSchema#string

Kyu-Pyo Kim

http://www.w3.org/2001/XMLSchema#string

Min Keun Cho

http://www.w3.org/2001/XMLSchema#string

Myung-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Tae Jun Song

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2014

Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies.

Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis.

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management.

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297.

P304

410-415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/WJON937E

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dongwook Oh

P577

2015-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281613778

http://www.w3.org/2001/XMLSchema#string

P698

28983339

http://www.w3.org/2001/XMLSchema#string

P932

5624689

http://www.w3.org/2001/XMLSchema#string